Bispecific antibody that binds to EGFR and B7-H3

JP2025522557A5Pending Publication Date: 2026-06-30フォートビタバイオロジクス(シンガポール)プライベートリミティド

View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office: JP · JP
Patent Type: Applications
Current Assignee / Owner: フォートビタバイオロジクス(シンガポール)プライベートリミティド
Filing Date: 2023-06-21
Publication Date: 2026-06-30

Application Information

Patent Timeline

21 Jun 2023

Application

30 Jun 2026

Publication

JP2025522557A5

IPC: C07K16/46; C07K16/30; C12N15/62; C12N15/13; C12N15/85; C12N5/10; C12N9/06; A61K39/395; A61K45/00; A61K45/06; A61K49/00; A61K39/00; A61P35/00; A61P31/00; A61P43/00; A61P35/02; A61P1/04; A61P11/00; A61P17/00; A61P1/02; A61P11/02; A61P11/04; A61K47/68; A61K47/55; G01N33/53; G01N33/577; C12N15/53; C12N15/31

CPC: A61P35/00; C12N15/85; C07K16/2863; C07K16/2827; C07K2317/31; C07K2317/21; C07K2317/24; C07K2317/92

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗

Get free access to AI patent search and analysis

Check patentability, review prior art and ask IP Agent with full patent context.

Smart Images

Figure 2023246891000001

Patent Text Reader

Abstract

The present invention provides a newly designed type of bispecific antibody molecule, particularly an anti-B7-H3 / EGFR bispecific antibody molecule that can simultaneously bind to B7-H3 and EGFR.

Need to check novelty before this filing date? Find Prior Art